Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib Study of Oncolytic Polio/Rhinovirus Recombinant Against Recurrent Malignant Glioma in Children

NCT03043391 is registered in ClinicalTrials.gov with Istari Oncology, Inc. as lead sponsor.

NCT NCT03043391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03043391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib Study of Oncolytic Polio/Rhinovirus Recombinant Against Recurrent Malignant Glioma in Children
Lead sponsor
Istari Oncology, Inc.
Phase
Phase 1
Overall status
Completed
Start date
November 7, 2017
Completion date
March 23, 2022
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, anaplastic oligoastrocytoma, anaplastic oligodendroglioma, atypical teratoid/rhabdoid tumor of brain, embryonal tumor of brain, ependymoma, glioblastoma, gliosarcoma, malignant glioma, medulloblastoma, pleomorphic xanthoastrocytoma of brain